Home › Multiple Myeloma › Illinois › Aurora
Multiple Myeloma clinical trials in Aurora, IL
3 studies for Multiple Myeloma are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Advocate Outpatient Center - Aurora, Aurora
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi away
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Rush - Copley Medical Center, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- St. Louis, MO23 studies
- Baldwin Park, CA23 studies
- Rochester, MN23 studies
- Washington, DC22 studies
Other studies in Aurora
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- Prostate Cancer9 studies
- Breast Cancer7 studies
- Melanoma7 studies
- Cancer (all types)5 studies
- Ovarian Cancer5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Acute Myeloid Leukemia4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Pancreatic Cancer4 studies
- Hypopharyngeal Cancer4 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.